Episode

#17, S2 The Future of Mesothelioma Treatment

Podcast
Thinking Thoracic
Published
Dec 2, 2025
Duration seconds
2912
Processing state
not_requested
Canonical source
https://thinkingthoracic.podbean.com/e/17-s2-the-future-of-mesothelioma-treatment/
Audio
https://mcdn.podbean.com/mf/web/3w6w4ebu4ffpsj23/TT-Dr_Joshua_Reuss65qmj.mp3
JSON
/v1/public/podcasts/thinking-thoracic-7116337/episodes/17-s2-the-future-of-mesothelioma-treatment
Markdown
/podcast/thinking-thoracic-7116337/17-s2-the-future-of-mesothelioma-treatment.md

Actions

  • POST https://stenobird.com/v1/public/podcasts/thinking-thoracic-7116337/episodes/17-s2-the-future-of-mesothelioma-treatment/transcription-requests
    Idempotently request low-priority transcript generation for this episode.
  • GET https://stenobird.com/podcast/thinking-thoracic-7116337/17-s2-the-future-of-mesothelioma-treatment.md
    Read the agent-friendly Markdown representation of this episode resource.

Summary

The latest episode of Thinking Thoracic dives into one of the most challenging diseases in thoracic oncology—malignant pleural mesothelioma. Host Erin Gillaspie, MD, speaks with Joshua Reuss, MD, a thoracic medical oncologist and clinical trials leader, about how immunotherapy, evolving surgical strategies, and global practice patterns are reshaping care for this rare cancer.